United Bio-Medtech Announces Board Resolution for Second Treasury Stock Buyback
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
United Bio-Medtech's board of directors resolved on May 6, 2026, to implement a second treasury stock buyback program, planning to repurchase 1.5 million common shares with an upper limit of NT$5.461 billion, primarily for transfer to employees.